Company / Free Cash Flow
vTv Therapeutics Inc. Free Cash Flow History
FY2016-FY2024 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Free Cash Flow
-$16.0M
FY2024
5-year range
-$23.1M / -$16.0M
FY2020-FY2024
Trend
+16.9%
vs FY2023
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Free Cash Flow has fluctuated over the past 9 years, ranging from -$48M in FY2018 to -$16M in FY2024.
Based on SEC 10-K filings.
-$16M in FY2024.
Improved from -$18M to -$16M over the past 2 years.
Free Cash Flow over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Key checks
Key Insights
- In FY2024, free cash flow increased 16.9% year-over-year.
- Lowest free cash flow in the period was in FY2018.
Company context
Key Data Points
- Altman Z-Score 0.85 (distress zone, below 1.8 threshold)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Free Cash FlowValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | - | - |
| FY2024 | -$16.0M | +16.9% |
| FY2023 | -$19.3M | -7.3% |
| FY2022 | -$18.0M | +22.0% |
| FY2021 | -$23.1M | +14.0% |
| FY2020 | -$26.9M | +39.8% |
| FY2019 | -$44.6M | +7.6% |
| FY2018 | -$48.3M | -30.4% |
| FY2017 | -$37.0M | -20.2% |
| FY2016 | -$30.8M | +26.4% |
As of FY2024 · SEC 10-K · Updated Jun 28, 2026